About this journal
Aims and scope
The Journal of Pain & Palliative Care Pharmacotherapy addresses advances in acute, chronic, and end-of-life symptom management as it relates to pharmacotherapy.
The Journal publishes original research, timely review articles, case reports, commentaries, book and media reviews, and articles on efficacy, safety, cost-effectiveness, availability, delivery systems, ethics, policy, philosophy, and other issues relevant to pharmacotherapy in the management of acute, chronic, and end-of-life pain and related symptoms. The journal also features a “Narratives in Pain” section written by everyday people who have chronic pain themselves or loved ones who do.
The Journal’s interdisciplinary, international, 32-member Editorial Board includes leading clinicians, investigators and analysts from the disciplines of bioethics, medicine, nursing, pharmaceutical sciences, psychology, social work, and health care policy.
Journal metrics
Usage
- 60K annual downloads/views
Citation metrics
- 0.9 (2023) Impact Factor
- 1.6 (2023) CiteScore (Scopus)
- 0.493 (2023) SNIP
- 0.355 (2023) SJR
Speed/acceptance
- 18 days avg. from submission to first decision
- 45 days avg. from submission to first post-review decision
- 21 days avg. from acceptance to online publication
- 43% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief
Laura Meyer-Junco, PharmD, BCPS, CPE
Clinical Assistant Professor and Clinical Pharmacist
University of Illinois Chicago College of Pharmacy
Rockford, IL
Evidence-based Pain Management and Palliative Care Editor
Philip J. Wiffen, MSc, MRPharmSPain Relief Unit
Churchill Hospital
Oxford, United Kingdom
Founding Editor and Former Editor-in-Chief
The late Arthur G. Lipman, PharmD
Editorial Board
Bioethics
Ben A. Rich, JD, PhDProfessor, and School of Medicine
Alumni Association Endowed Chair of Bioethics
University of California, Davis Health System
Sacramento, California
Medicine
Anita Gupta, DO, PharmDVice-Chair of Regional Anesthesiology and Pain Medicine
Associate Professor and Medical Director, University Pain Institute
Department of Anesthesiology and Perioperative Medicine
Drexel University College of Medicine/Hahnemann University Hospital
Philadelphia, Pennsylvania
Jairo Moyano, MD, PhD
Chief of Pain Medicine and Palliative Care Program
University Hospital Fundación Santa Fe de Bogotá
Clinical Professor El Bosque University
Clinical Professor of Anesthesiology, University of the Andes
Bogotá, Colombia
Lee S. Simon, MD
Principal, SDG LLC
Former Harvard Medical School faculty member
Former Division Head, Center for Drug Evaluation
and Research, U.S. Food & Drug Administration
Cambridge, Massachusetts
Knox H. Todd, MD, MPH
Director, EMLine
Adjunct Professor of Emergency Medicine
The University of Texas Medical School at Houston
Mendoza, Argentina
Eugene Viscusi, MD
Professor of Anesthesiology
Director of Acute Pain Management
Thomas Jefferson University
Philadelphia, Pennsylvania
Nursing
Paul M. Arnstein, RN, PhDClinical Nurse Specialist for Pain Relief
Massachusetts General Hospital
Associate Professor
MGH Institute of Health Professions
Boston, Massachusetts
Patrick J.Coyne, MSN,ACHPN,ACNS-BC,FAAN,FPCN
Program Director, Palliative Care
Assistant Professor of Medicine and Nursing
Medical University of South Carolina
Charleston, South Carolina
Debra B. Gordon, RN-BC, MS, DNP, ACNS-BC, FAAN
Department of Anesthesiology and Pain Medicine,
University of Washington
Seattle, Washington
Patient Advocacy and Education
Yvette Colón, PhD, ACSW, BCD
Associate Professor, School of Social Work
Eastern Michigan University
Ypsilanti, Michigan
Pharmaceutical Sciences
David Craig, PharmDPharmacist Lead, Acute Pain & Supportive Care
Moffitt Cancer Center and Research Institute
Tampa, Florida
Erin Fox, PharmD, BCPS, FASHP
Director, Drug Information Service
University of Utah Health Care
Adjunct Associate Professor of Pharmacotherapy
College of Pharmacy, University of Utah
Salt Lake City, Utah
Ewan McNicol, PharmD, MS
Clinical Pharmacist
Departments of Pharmacy and Anesthesia
Tufts Medical Center
Assistant Professor of Anesthesiology
Tufts University School of Medicine
Boston, Massachusetts
Mandy Mullins, PharmD, BCPS
Clinical Pharmacy Specialist - Pain Management and Palliative Care
VA St. Louis Medical Center
Jefferson Barracks Division
Professor Emeritus of Pharmacotherapy
College of Pharmacy
University of Utah
Salt Lake City, Utah
Dave Peterson, PharmD, BCPS
University of Utah Health
Drug Information Service
Policy, Legal, and Regulatory Affairs
James H. Ruble, PharmD, JDAssociate Professor (Clinical)
Department of Pharmacotherapy
College of Pharmacy
University of Utah
Salt Lake City, Utah
Abstracting and indexing
• Adis International Ltd.
• British Library Board
• EBSCOhost
• EMBASE
• Scopus, 1993-2001
• National Library of Medicine; PubMed/MEDLINEOCLC
• Ovid
• Periodica Islamica, 1992-
• Plexus Publishing, Inc.; Biology Digest, vol.16, no.1, 2002-vol.18, no.3, 2004
• ProQuest
Open access
Journal of Pain & Palliative Care Pharmacotherapy is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Use our APC finder to calculate your article publishing charge
4 issues per year
Currently known as:
- Journal of Pain & Palliative Care Pharmacotherapy (2002 - current)
Formerly known as
- The Hospice Journal (1985 - 2001)
Incorporates
- Journal of Pharmaceutical Care in Pain & Symptom Control (1993 - 2001)
Advertising information
Would you like to advertise in Journal of Pain & Palliative Care Pharmacotherapy?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Journal of Pain & Palliative Care Pharmacotherapy.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors